[{"from": "human", "value": "Could you provide a description of this molecule? [C][C][=Branch1][C][=C][C@@H1][C][C][C@][Branch2][=Branch1][Ring1][C@H1][Ring1][Branch1][C@H1][C][C][C@@H1][C@][Branch2][Branch1][#Branch1][C][C][C@@H1][Branch2][Ring1][#C][C][Branch2][Ring1][#Branch1][C@@H1][Ring1][=Branch1][C][C][C@][Ring1][#Branch2][Branch1][N][C@@][Ring1][=C][Branch1][=Branch1][C][C][Ring2][Ring1][C][C][C][Branch1][C][C][C][O][C][=Branch1][C][=O][C][C][Branch1][C][C][Branch1][C][C][C][=Branch1][C][=O][O][C][C][=Branch1][C][=O][O]"}, {"from": "gpt", "value": "The molecule is investigated in clinical trials for treating HIV infection. Bevirimat is a solid. This compound belongs to the androgens and derivatives, which are hydroxylated C19 steroid hormones. They are known to favour the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. Bevirimat targets the protein gag-pol polyprotein. Bevirimat is derived from a betulinic acid-like compound, first isolated from Syzygium claviflorum, a Chinese herb. It is not currently FDA-approved, but is undergoing clinical trials conducted by the pharmaceutical company Panacos."}]